The table below shows ACADIA PHARMACEUTICALS INC's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
$109.84M
$157.72M
$16.70M
-$114.03M
-$125.66M
-$136.17M
Capital expenditure
$4.69M
$523.00K
$50.00K
$0.00
$1.12M
$7.59M
Investing cash flow
-$302.56M
-$30.54M
$32.00M
$73.24M
-$71.10M
$192.51M
Dividends paid
-
-
-
-
-
ACAD operating cash flow (10-K history)
ACADIA PHARMACEUTICALS INC reported operating cash flow of $109.84M for fiscal year 2025. That is down 30.4% from $157.72M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$208.41M (FY 2016) to $109.84M. Figures come from the company's audited annual reports as filed with the SEC.
